Rho-kinase-dependent pathway mediates the hepatoprotective effects of sorafenib against ischemia/reperfusion liver injury in rats with nonalcoholic steatohepatitis

Liver Transplantation

Volumn 18, Issue 11, 2012, Pages 1371-1383

  Yang, Ying Ying ^a,b   Huang, Yi Tsau ^b,c   Lee, Tzung Yan ^d   Chan, Che Chang ^a,b   Yeh, Yi Chen ^a,b   Lee, Kuei Chuan ^a,b   Lin, Han Chieh ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CASPASE 9; CD45 ANTIGEN; CHEMOATTRACTANT; FASUDIL; GRANULOCYTE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; PROTEIN BCL XL; RHO KINASE; SORAFENIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; KERATINOCYTE; LEUKOCYTE; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEMODYNAMICS; INFLAMMATION; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; NECROSIS; NIACINAMIDE; PHENYLUREA COMPOUNDS; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; RHO-ASSOCIATED KINASES; RNA, MESSENGER; TRANSPLANTATION, HOMOLOGOUS;

EID: 84868137269     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23520     Document Type: Article

References (28)

1. Selzner M, Clavien PA,. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-113.
2. Hui AM, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miyagawa S,. Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 1994; 20: 1287-1293.
3. Alwayn IP, Porte RJ,. How to make steatotic livers suitable for transplantation. Liver Transpl 2007; 13: 480-482.
4. Sun CK, Zhang XY, Zimmermann A, Davis G, Wheatley AM,. Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. Transplantation 2001; 72: 1625-1631.
5. Gujral JS, Bucci TJ, Farhood A, Jaeschke H,. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 2001; 33: 397-405.
6. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ,. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 2000; 32: 169-173.
7. Hennenberg M, Trebicka J, Kohistani Z, Stark C, Nischalke HD, Krämer B, et al. Hepatic and HSC-specific sorafenib effects in rats with established secondary biliary cirrhosis. Lab Invest 2011; 91: 241-251.
8. Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, et al. Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis. Hepatology 2011; 54: 573-585.
9. Klintman D, Li X, Santen S, Schramm R, Jeppsson B, Thorlacius H,. p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury. Ann Surg 2005; 242: 830-838.
10. Shimada H, Rajagopalan LE,. Rho-kinase mediates lysophosphatidic acid-induced IL-8 and MCP-1 production via p38 and JNK pathways in human endothelial cells. FEBS Lett 2010; 584: 2827-2832.
11. Verhoef PA, Estacion M, Schilling W, Dubyak GR,. P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol 2003; 170: 5728-5738.
12. Shiotani S, Shimada M, Suehiro T, Soejima Y, Yosizumi T, Shimokawa H, Maehara Y,. Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats. Transplantation 2004; 78: 375-382.
13. Kuroda S, Tashiro H, Igarashi Y, Tanimoto Y, Nambu J, Oshita A, et al. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver. J Hepatol 2012; 56: 146-152.
14. Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T,. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol 2009; 157: 258-270.
15. Lin HC, Yang YY, Tsai TH, Huang CM, Huang YT, Lee FY, et al. The relationship between endotoxemia and hepatic endocannabinoids in cirrhotic rats with portal hypertension. J Hepatol 2011; 54: 1145-1153.
16. Yang YY, Huang YT, Lin HC, Lee FY, Lee KC, Chau GY, et al. Thalidomide decreases intrahepatic resistance in cirrhotic rats. Biochem Biophys Res Commun 2009; 380: 666-672.
17. Cutrn JC, Perrelli MG, Cavalieri B, Peralta C, Rosell Catafau J, Poli G,. Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic Biol Med 2002; 33: 1200-1208.
18. Broughton BR, Walker BR, Resta TC,. Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2008; 294: L797-L806.
19. Versteilen AM, Blaauw N, Di Maggio F, Groeneveld AB, Sipkema P, Musters RJ, Tangelder GJ,. Ï-Kinase inhibition reduces early microvascular leukocyte accumulation in the rat kidney following ischemia-reperfusion injury: roles of nitric oxide and blood flow. Nephron Exp Nephrol 2011; 118: e79-e86.
20. Ikeda H, Kume Y, Tejima K, Tomiya T, Nishikawa T, Watanabe N, et al. Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats. Am J Physiol Gastrointest Liver Physiol 2007; 293: G911-G917.
21. Chuluyan HE, Lang BJ, Yoshimura T, Kenney JS, Issekutz AC,. Chemokine production and adhesion molecule expression by neural cells exposed to IL-1, TNF alpha and interferon gamma. Life Sci 1998; 63: 1939-1952.
22. Teoh N, Leclercq I, Pena AD, Farrell G,. Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications for preconditioning. Hepatology 2003; 37: 118-128.
23. Lee WY, Kubes P,. Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs. J Hepatol 2008; 48: 504-512.
24. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut 2012; 61: 416-426.
25. Feldstein AE, Canbay A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ,. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003; 125: 437-443.
26. Song G, Ouyang G, Bao S,. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9: 59-71.
27. Kobayashi M, Takeyoshi I, Yoshinari D, Matsumoto K, Morishita Y,. P38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver. Surgery 2002; 131: 344-349.
28. Dhillon AS, Kolch W,. Untying the regulation of the Raf-1 kinase. Arch Biochem Biophys 2002; 404: 3-9.